| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-10 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |